FDA U.S. Agent for medical device establishments in South Korea
A medical device establishment in South Korea that exports to the United States must register with FDA and name a U.S. Agent located in the U.S. (21 CFR 807.40). In the 12 months from 2025-10 to 2026-09, FDA refused 1,347 import lines from South Korea, and 51 FDA import alerts list firms from South Korea.
FDA data for South Korea
Figures from FDA public data, retrieved 2026-10-21. Recall counts are by the recalling firm's country.
Import refusals, 2025-10 to 2026-09
| Refused import lines | 1,347 |
| Refusals citing registration or listing problems | NOT LISTED-118 · 507 FRNMFGREG-3280 · 439 |
Most refused product industries
| Code | Count | |
|---|---|---|
| 79 | General & Plastic Surgery | 220 |
| 86 | Ophthalmic | 98 |
Most common refusal charges
| Code | Count |
|---|---|
| NOT LISTED-118 The article is subject to refusal of admission pursuant to section 801(a)(3) of the FD&C Act in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. Based on the information… | 507 |
| FRNMFGREG-3280 The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. Based on information available to FDA, i… | 439 |
| UNAPPROVED-75 The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA). | 317 |
| NO 510(K)-508 The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantial… | 206 |
| NO PMA-237 The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for prem… | 201 |
Import alerts listing South Korea firms
Import alerts that list at least one firm in South Korea: 51. Recently updated:
- Import Alert 16-39: Detention Without Physical Examination of Ready-to-Eat Seafood for Listeria monocytogenes
- Import Alert 20-07: Detention Without Physical Examination of Juice from Foreign Processors Not in Compliance with Juice HACCP Regulation
- Import Alert 45-02: Detention Without Physical Examination and Guidance of Foods Containing Illegal and/or Undeclared Colors.
- Import Alert 45-06: Detention without Physical Examination of Stevia Leaves, Crude Extracts of Stevia Leaves and foods Containing Stevia Leaves and/or Stevia Extracts
- Import Alert 99-05: Detention Without Physical Examination Of Raw Agricultural Products for Pesticides
- Import Alert 99-08: Detention without Physical Examination of Processed Human and Animal Foods for Pesticides
Recalls by South Korea firms, last 5 years
28 (Class II: 26, Class I: 2)
Recent recall reasons:
- 2026-09 Utilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in pati…
- 2026-05 The devices were distributed without required FDA premarket clearance or approval.
- 2026-03 Reports of devices sparking/popping and potentially burning patients.
What the rule requires
Every foreign establishment that manufactures, prepares, propagates, compounds or processes a medical device imported into the United States must register with FDA, list its devices, and designate a single U.S. Agent. Registration is renewed every year between October 1 and December 31, and FDA's annual establishment fee must be paid first.
- Foreign manufacturers, contract manufacturers, contract sterilizers, specification developers, repackagers, relabelers and some kit assemblers of devices exported to the U.S.
- Initial importers in the U.S. register separately; they do not need a U.S. Agent
Deadlines
- Register within 30 days of beginning an operation that requires registration
- Renew annually between October 1 and December 31 (21 CFR 807.22)
- Pay the annual establishment registration user fee before submitting
Steps
- Pay FDA's annual establishment registration fee through the Device Facility User Fee website and get a Payment Identification Number
- Create an account in FDA's FURLS Device Registration and Listing Module (DRLM)
- Your official correspondent enters the establishment, owner/operator, U.S. Agent and device listings
- FDA emails the U.S. Agent to confirm the designation
- Keep your FEI and owner/operator number on file
Common mistakes
- Paying the user fee but never completing the registration in DRLM
- Naming a U.S. Agent who has not agreed. The agent must confirm in FDA's system
- Forgetting to list each device under the correct product code
- Believing that registration means FDA has cleared or approved the device. It does not
How US Agent Desk helps
We serve as your U.S. Agent, prepare the registration data in your language for your company's officer to submit, confirm the designation when FDA asks, and check FDA's public records for your company every morning. Prices start at $990 per year.
Check if you need a U.S. Agent See prices
Independent private service. Not affiliated with the U.S. FDA. Not legal advice.